Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Energy hedge fund BlueGold liquidates entire portfolio

Monday, April 09, 2012

Opalesque Team: BlueGold Capital Management LLP, the $1bn energy hedge fund co-founded by Pierre Andurand and Dennis Crema, is liquidating after losing 34% last year, according to various media reports.

The London-based fund house, which invested mostly in energy derivatives, wrote to investors to announce the liquidation of the entire portfolio and the undertaking of an "orderly closure." Investors will receive about 98% of their capital, the letter said, without giving a reason for the decision, The Telegraph reported.

BlueGold managed $2.2bn at its peak. It started trading in February 2008 and did well that year, returning 209%, and then 55% in 2009 and 13% in 2010, Bloomberg said.

But we had been hearing about BlueGold’s losses for a year. BlueGold was one of the worst performers among commodity hedge funds in 2011, industry data gathered by Reuters shows. It lost 35% then and its asset base shrunk to about $1.2bn from $2bn a year a before.

An investor who redeemed money from BlueGold in January told Reuters he still regarded the fund as "a pretty talented group" that may have given ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its